Skip to main content
Premium Trial:

Request an Annual Quote

Eurofins Wins $30M Air Force Contract to Expand Capacity for COVID-19 Test Reagents

NEW YORK – The US Department of the Air Force and the Department of Health and Human Services awarded Eurofins Genomics US a $30 million contract to build a new production facility and to expand manufacturing capacity for the reagents used in COVID-19 diagnostic tests.

The new facility will focus on producing GMP-grade DNA, used in all PCR-based COVID-19 tests.

These DNA species, also known as oligos, are a key testing reagent but are vulnerable to supply shortages and manufacturers can face capacity constraints during peaks in demand, as has occurred throughout the pandemic. Eurofins' partnership with DAF and HHS aims to address that constraint.

The new facility will be located in Louisville, Kentucky, next to the company's US logistical hub. The proximity of the two facilities is expected to facilitate the fast and reliable distribution of reagents across the country.

Eurofins has been active in COVID-19 testing, having recently added SARS-CoV-2 mutation detection capabilities to its RT-PCR-based COVID-19 testing kit.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.